Keywords: abbott, raises, humira, estimates, usas, laboratories, raised

Abbott raises Humira estimates

Article | 09 June 2003

Print This

The USAs Abbott Laboratories has raised its sales expectations for the anti-tumor necrosis factor antibody Humira (adalimumab) on the back ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in